ACM
GH icon

Adalta Capital Management’s Guardant Health GH Stock Holding History

Adalta Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.05M Sell
60,310
-1,163
-2% -$126K 3.97% 10
2026
Q1 		$5.68M Sell
61,473
-1,815
-3% -$182K 2.72% 12
2025
Q4 		$6.46M Hold
63,288
– – 2.89% 12
2025
Q3 		$3.95M Sell
63,288
-75
-0.1% -$4.08K 1.8% 16
2025
Q2 		$3.3M Sell
63,363
-300
-0.5% -$13.4K 1.65% 16
2025
Q1 		$2.71M Sell
63,663
-4,600
-7% -$198K 1.44% 19
2024
Q4 		$2.09M Sell
68,263
-2,700
-4% -$76K 1.09% 21
2024
Q3 		$1.63M Sell
70,963
-60
-0.1% -$1.7K 0.84% 26
2024
Q2 		$2.05M Hold
71,023
– – 1.12% 19
2024
Q1 		$1.47M Buy
71,023
+9,565
+16% +$205K 0.81% 26
2023
Q4 		$1.66M Sell
61,458
-19,762
-24% -$518K 1.01% 24
2023
Q3 		$2.41M Buy
81,220
+45
+0.1% +$1.58K 1.64% 16
2023
Q2 		$2.91M Sell
81,175
-700
-0.9% -$20.1K 1.94% 15
2023
Q1 		$1.92M Sell
81,875
-1,890
-2% -$54K 1.34% 20
2022
Q4 		$2.28M Sell
83,765
-18,635
-18% -$853K 1.61% 18
2022
Q3 		$5.51M Sell
102,400
-1,920
-2% -$98.6K 3.96% 9
2022
Q2 		$4.21M Sell
104,320
-2,500
-2% -$124K 2.73% 12
2022
Q1 		$7.08M Sell
106,820
-3,440
-3% -$235K 3.53% 10
2021
Q4 		$11M Buy
110,260
+3,350
+3% +$346K 5.09% 6
2021
Q3 		$13.4M Sell
106,910
-418
-0.4% -$49.7K 7.4% 2
2021
Q2 		$13.3M Buy
107,328
+183
+0.2% +$24.6K 7.26% 2
2021
Q1 		$16.4M Sell
107,145
-1,300
-1% -$196K 9.44% 2
2020
Q4 		$14M Sell
108,445
-60
-0.1% -$6.9K 8.82% 2
2020
Q3 		$12.1M Buy
108,505
+150
+0.1% +$13.7K 8.85% 2
2020
Q2 		$8.79M Sell
108,355
-2,755
-2% -$222K 7% 2
2020
Q1 		$7.73M Sell
111,110
-3,625
-3% -$278K 7.02% 2
2019
Q4 		$8.97M Buy
114,735
+2,320
+2% +$167K 5.64% 3
2019
Q3 		$7.17M Sell
112,415
-925
-0.8% -$81.5K 4.75% 3
2019
Q2 		$9.78M Buy
+113,340
New +$8.66M 6.43% 2

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Adalta Capital Management's GH Position: Q2 2026 in Review

Adalta Capital Management reduced its Guardant Health (GH) stake by 1.9% in Q2 2026, selling an estimated $126K and leaving 60,310 shares worth $9.05M. The position accounts for 3.97% of the portfolio, ranked #10.

Adalta Capital Management first reported a position in GH in Q2 2019 and has held it in 29 quarters since. The position peaked at $16.4M in Q1 2021. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Adalta Capital Management held 60,310 shares of Guardant Health worth $9.05M as of Q2 2026.
  • Adalta Capital Management sold 1,163 Guardant Health shares in Q2 2026, an estimated $126K.
  • Guardant Health made up 3.97% of Adalta Capital Management's portfolio in Q2 2026, its #10 holding.
  • Adalta Capital Management first reported a position in Guardant Health in Q2 2019 and has held it in 29 quarters since.
  • Adalta Capital Management's Guardant Health position peaked at $16.4M in Q1 2021.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Adalta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.